Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cogene Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$37M
Portfolio companies 6
Rounds per year 0.43
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 5
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
Summary

Cogene Ventures is the famous VC, which was founded in 2000. The main department of described VC is located in the Houston. The venture was found in North America in United States.

The standard case for the fund is to invest in rounds with 7 partakers. Despite the Cogene Ventures, startups are often financed by MDS Capital, U.S. Venture Partners (USVP), RBC Venture Partners. The meaningful sponsors for the fund in investment in the same round are Vulcan Capital, U.S. Venture Partners (USVP), Schroder Ventures. In the next rounds fund is usually obtained by Sofinnova Investments, RCT BioVentures, Novartis Venture Fund.

Among the various public portfolio startups of the fund, we may underline Catalyst Biosciences, Raven Biotechnologies, Neuromed Pharmaceuticals The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Life Science, Health Care. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Opposing the other organizations, this Cogene Ventures works on 51 percentage points more the average amount of lead investments. The increased amount of exits for fund were in 2011. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2003. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cogene Ventures:
Typical Co-investors
Cogene Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cogene Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ABR Capital Management California, San Francisco, United States
Agile Equity New York, New York, United States
Beijing Falcon Investment Beijing, Beijing, China
Burnham Holdings Lancaster, Pennsylvania, United States
Center for Innovation Arlington, Texas, United States
Charter Life Sciences California, Santa Clara, United States
Christie Digital Systems USA California, Cypress, United States
General Global Capital -
Mingde Zhiyuan Touzi China, Guangdong, Tianjin
MyEG Capital Malaysia, Petaling Jaya, Selangor
Nex Cubed California, San Francisco, United States
One Planet California, United States, Walnut Creek
Oxygen Capital Partners, LLC California, Santa Monica, United States
Shanhang Capital Investment -
Talk City Massachusetts, North Andover, United States
Tsukuba Exceed Fund -
Zhonghua Chuangxin Jijinhui -
ZRC Capital Beijing, China, Haidian

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MacroGenics

Biotechnology
Health Care
Manufacturing
$30M15 Oct 2004 Maryland, United States

Rejuvenon

Biotechnology
Developer Platform
Medical
$37M23 Jun 2004 The Woodlands, Texas, United States

TransMolecular

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$33M01 Mar 2004 Birmingham, Alabama, United States

Neuromed Pharmaceuticals

Biopharma
Biotechnology
Cyber Security
Enterprise Applications
Health Care
Information Technology
Project Management
Telecommunications
$32M04 Nov 2003 Vancouver, British Columbia, Canada

Catalyst Biosciences

Biotechnology
Health Care
Life Science
Medical
Medical Device
Pharmaceutical
Therapeutics
$60M20 Mar 2003 South San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cogene Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 9
Average round size 37M
Rounds per year 0.43
Peak activity year 2004
Lead investments 0
Follow on index 0.33
Exits 5
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

MacroGenics

Biotechnology
Health Care
Manufacturing
$30M15 Oct 2004 Maryland, United States

Rejuvenon

Biotechnology
Developer Platform
Medical
$37M23 Jun 2004 The Woodlands, Texas, United States

TransMolecular

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$33M01 Mar 2004 Birmingham, Alabama, United States

Neuromed Pharmaceuticals

Biopharma
Biotechnology
Cyber Security
Enterprise Applications
Health Care
Information Technology
Project Management
Telecommunications
$32M04 Nov 2003 Vancouver, British Columbia, Canada

Catalyst Biosciences

Biotechnology
Health Care
Life Science
Medical
Medical Device
Pharmaceutical
Therapeutics
$60M20 Mar 2003 South San Francisco, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: